Pure Global AI
NCT06377124Not yet recruiting

A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Lung Cancer Patients

A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Patients With Lung Cancer - A Pragmatic Randomized Controlled Trial With Mixed-method Evaluation
The University of Hong KongClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Lung Cancer
Drug/Device/Intervention
3S intervention
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
The University of Hong Kong
Location
Hong Kong, China
Timeline & enrollment
Phase
N/A
Start date
Apr 22, 2024
End date
Jun 30, 2026
Enrollment
320 participants
Primary outcome

Change in health-related quality of life

Summary

Lung cancers patients often experience multiple symptoms (e.g. fatigue, dyspnea, distress,
 depression, sleep disturbance). The current study attempts to explore the efficacy of the
 Smart Self-Management Support Programme (3S) in improving quality of life of patients using
 self-management support programme with mobile devices.

ICD-10 classifications
Carcinoma in situ: Bronchus and lungSecondary malignant neoplasm of lungMalignant neoplasm of bronchus and lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm: Overlapping lesion of bronchus and lung
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06377124
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06377124 through Pure Global AI's free database. This phase not specified trial is sponsored by The University of Hong Kong and is currently Not yet recruiting. The study focuses on Lung Cancer. Target enrollment is 320 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.